InsidersTradesSigma
큐리언트 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 큐리언트 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 큐리언트 has recorded 103 public disclosures. Market capitalisation: €814.2bn. The latest transaction was filed on 3 April 2026 (Purchase). Among the most active insiders: 동구바이오제약. Every trade is openly available.
101
Insider Decl.
n/a
Thresholds
€42,602
32 ops.
Buy Volume
n/a
5 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,383 of 28,065 companies
17.0
score / 100
Value25
Quality9
FCF yld-4.0%
Earn yld-3.7%
EV/EBITDA·
ROE-75%
Gross mgn13%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 April 2026
Declarations103 total
Other
Other(filed)
Other
Other(filed)
80,000 sharesKRXDART:20260303002340
1,487,693 sharesKRXDART:20241129000711
1,661,065 sharesKRXDART:20241029000023
1,661,065 sharesKRXDART:20241028000395
5,037,281 sharesKRXDART:20240805000130
25 of 103 declarations
About 큐리언트
큐리언트 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative treatments for various diseases.